BioNTech and partner DualityBio are accelerating the development of their B7-H3 antibody-drug conjugate into a phase 3 trial for metastatic castration-resistant prostate cancer (mCRPC). | BioNTech and ...
Established partnership with Kelun-Biotech expanding pipeline and accelerating combination strategy with CR-001, PD-1 x VEGF bispecific antibody, and multiple ADCs ASCEND Phase 1/2 global clinical ...
Creative Enzymes stands as a leading provider of enzyme-related services and solutions. Committed to innovation and excellence, the organization supports research in enzymology and biotechnology by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results